Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1416-1421

  Proclemer, Alessandro ^a   Muser, Daniele ^a   Campana, Andrea ^b   Zoni Berisso, Massimo ^c   Zecchin, Massimo ^d   Locatelli, Alessandro ^e   Brieda, Marco ^f   Gramegna, Lorena ^g   Santarone, Mauro ^h   Chiodi, Leandro ⁱ   Mazzone, Patrizio ^j   Rebellato, Luca ^a   Facchin, Domenico ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b Medicina Immunotrasfusionale Ospedale San Giovanni di Dio e Ruggi d'Aragona   (Italy)

^c Ospedale A Micone   (Italy)

^d Azienda Ospedaliero Universitaria Ospedali Riuniti   (Italy)

^e BOLOGNINI HOSPITAL   (Italy)

^f S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^g SANTA CHIARA HOSPITAL   (Italy)

^h VALDUCE HOSPITAL   (Italy)

ⁱ Ospedale S Maria Annunziata   (Italy)

^j SAN RAFFAELE HOSPITAL   (Italy)

more..

Author keywords

Implantable cardioverter defibrillator; Long term outcome; Primary prevention; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DRUG USE; DUAL CHAMBER PACEMAKER; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE CHAMBER PACEMAKER; SUDDEN CARDIAC DEATH; THERAPY EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LONG-TERM OUTCOME; PRIMARY PREVENTION; SUDDEN CARDIAC DEATH;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84885321151     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.042     Document Type: Article

References (36)

1. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death In patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882-90.
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an Implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352(3):225-37.
3. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an Implantable defibrillator In advanced chronic heart failure. N Engl J Med 2004;350(21):2140-50.
4. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator Implantation In patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350(21): 2151-8.
5. Moss AJ,HallWJ, CannomDS, et al. Improved survivalwith an Implanted defibrillator In patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl JMed 1996;335(26): 1933-40.
6. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic Implantation of a defibrillator In patients with myocardial Infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-83.
7. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death In Idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002;105(12):1453-8.
8. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361(14):1329-38.
9. Lee KL, Hafley G, Fisher JD, et al. Effect of Implantable defibrillators on arrhythmic events and mortality In the multicenter unsustained tachycardia trial. Circulation 2002;106(2):233-8.
10. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators In primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138(6):445-52.
11. Merkely B, Roka A, Kutyifa V, et al. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace 2010;12(5):692-701.
12. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and Implantable cardioverter-defibrillators: calendar year 2009 -a World Society of Arrhythmia's project. Pacing Clin ElectroPhysiol Aug. 34 2011(8):1013-27.
13. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and ElectroPhysiology Society (iCPES) project. Pacing Clin ElectroPhysiol 2008;31(9): 1202-12.
14. Proclemer A, Ghidina M, Gregori D, et al. Impact of the main Implantable cardioverter-defibrillator trials In clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 2009;11(4):465-75.
15. Santini M, Russo M, Botto G, et al. Clinical and arrhythmic outcomes after Implantation of a defibrillator for primary prevention of sudden death In patients with post-myocardial Infarction cardiomyopathy: the Survey to Evaluate Arrhythmia Rate In high-risk Mi patients (SEARCH-Mi). Europace 2009;11(4):476-82.
16. Lunati M, Bongiorni MG, Boriani G, et al. Linee guida AiAC 2006 all'impianto di pacemaker, dispositivi per la resincronizzazione cardiaca (CRT) e defibrillatori automatici Impiantabili (iCD). GiAC 2005;8:1-58.
17. ZipesDP, CammAJ, BorggrefeM, et al. ACC/AHA/ESC 2006 guidelines formanagement of patientswith ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed In collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8(9):746-837.
18. Daubert JP, Zareba W, Cannom DS, et al. Inappropriate Implantable cardioverterdefibrillator shocks In MADiT Ii: frequency, mechanisms, predictors, and survival Impact. J Am Coll Cardiol 2008;51(14):1357-65.
19. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic Importance of defibrillator shocks In patients with heart failure. N Engl J Med 2008;359(10):1009-17.
20. SweeneyMO,WathenMS, Volosin K, et al. Appropriate and Inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention Implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111(22):2898-905.
21. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia In patients with Implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110(17):2591-6.
22. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia In patients with coronary artery disease. Circulation 2001;104(7):796-801.
23. Goldenberg I, Gillespie J, Moss AJ, et al. Long-term benefit of primary prevention with an Implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial Ii. Circulation 2010;122(13):1265-71.
24. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic Implantation of a defibrillator In the multicenter automatic defibrillator Implantation trial Ii. Circulation 2006;113(24):2810-7.
25. Di Biase L, Santangeli P, Burkhardt DJ, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms In patients with Ischemic cardiomyopathy. J Am Coll Cardiol 2012;60(2):132-41.
26. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical stormin patientswith transvenous Implantable cardioverter- defibrillators: Incidence, management and prognostic Implications. J Am Coll Cardiol 1998;32(7):1909-15.
27. Parmar MB, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoInts. Stat Med 1998;17: 2815-34.
28. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization In mildly symptomatic heart failure patients and In asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52(23):1834-43.
29. Hurst TM, Hinrichs M, Breidenbach C, Katz N,Waldecker B. Detection of myocardial Injury during transvenous Implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999;34(2):402-8.
30. Gasparini M, Menozzi C, Proclemer A, et al. A simplified biventricular defibrillator with fixed long detection Intervals reduces Implantable cardioverter defibrillator (iCD) Interventions and heart failure hospitalizations In patients with nonischaemic cardiomyopathy Implanted for primary prevention: the RELEVANT [Role of long dEtectionwindowprogramming In patientswith LEft VentriculAr dysfunction, Non-ischemic eTiology In primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30(22):2758-67.
31. Saeed M, Neason CG, Razavi M, et al. Programming antitachycardia pacing for primary prevention In patients with Implantable cardioverter defibrillators: results from the PROVE trial. J Cardiovasc ElectroPhysiol 2010;21(12):1349-54.
32. Di Biase L, Gasparini M, Lunati M, et al. Antiarrhythmic effect of reverse ventricular remodeling Induced by cardiac resynchronization therapy: the InSync ICD (implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol 2008;52(18):1442-9.
33. Myerburg RJ, Hendel RC. Expanding risk-profiling strategies for prediction and prevention of sudden cardiac death. J Am Coll Cardiol 2010;56(3):215-7.
34. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of Implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol Sep. 30 2008;52(14):1111-21.
35. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of Implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006;97(8):1255-61.
36. VAN Welsenes GH, VAN Rees JB, Thijssen J, et al. Primary prevention Implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life. J Cardiovasc ElectroPhysiol December 2011;22(12):1346-50.